The controversial diabetic drug Avandia, alleged to cause heart attacks and strokes, is still available in the Kenyan consumer market, despite a three-year old report condemning its use in the Western world.
In interviews with The EastAfrican,The controversial diabetic drug Avandia, alleged to cause heart attacks and strokes, is still available in the Kenyan consumer market, despite a three-year old report condemning its use in the Western world. pharmacists, medical representatives and doctors confirmed that prescriptions for Avandia are still being offered to older patients.
The practice highlights loopholes in Kenya’s drug market as patient seek cheaper products and companies look to push sales.
In Uganda, though Avandia is registered by the National Drug Authority (NDA), it is not on the market.
GlaxoSmithKline country manager Nathan Wasolo said they registered the drug with NDA but did not import it for the Ugandan market.

http://www.theeastafrica...0/-/n4hkqsz/-/index.html